CureVac
(NASDAQ) CVAC
CureVac Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$70.74M
Net Income (TTM)
$128.82M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
CVAC News
Why CureVac Stock Plunged Today
Why CureVac Stock Is Sinking Today
CVAC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout CureVac
Industry
Biotechnology
Sector
Health CareEmployees
983
CEO
Alexander Zehnder, MD, MBA
Website
www.curevac.comHeadquarters
Tübingen, 72076, DE
CVAC Financials
Key Financial Metrics (TTM)
Gross Margin
93%
Operating Margin
2%
Net Income Margin
2%
Return on Equity
18%
Return on Capital
17%
Return on Assets
11%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$429.35M
Operating Income
$177.68M
EBITDA
$209.69M
Operating Cash Flow
$101.85M
Capital Expenditure
$18.44M
Free Cash Flow
$83.41M
Cash & ST Invst.
$485.37M
Total Debt
$38.97M
CureVac Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$54.13M
-89.0%
Gross Profit
$53.76M
-88.6%
Gross Margin
99.31%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
825
N/A
Net Income
$273.23M
-19.2%
EBITDA
$317.86M
-15.3%
Quarterly Fundamentals
Net Cash
$384.15M
-25.4%
Accounts Receivable
$27.36M
+31.5%
Inventory
$541.00K
+15.1%
Long Term Debt
$30.30M
-13.2%
Short Term Debt
$4.76M
-8.9%
Return on Assets
11.31%
N/A
Return on Invested Capital
16.62%
N/A
Free Cash Flow
$29.54M
-91.6%
Operating Cash Flow
$29.86M
-91.6%